Thailand - Delayed Quote THB

Mega Lifesciences Public Company Limited (MEGA.BK)

25.75
-1.00
(-3.74%)
At close: 4:37:14 PM GMT+7
Loading Chart for MEGA.BK
  • Previous Close 26.75
  • Open 26.75
  • Bid --
  • Ask --
  • Day's Range 25.50 - 27.00
  • 52 Week Range 25.50 - 41.00
  • Volume 2,149,735
  • Avg. Volume 1,030,242
  • Market Cap (intraday) 22.451B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 11.29
  • EPS (TTM) 2.28
  • Earnings Date Aug 11, 2025 - Aug 15, 2025
  • Forward Dividend & Yield 1.60 (5.98%)
  • Ex-Dividend Date Mar 7, 2025
  • 1y Target Est 32.57

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; diabetics; eyes, heart, and skin care; pain, sleeping, well-being, herbal, and cough and colds; and vitamins, probiotics, medical and sports nutrition, as well as kids', men's, and women's care products. The company also offers prescription medicines in the areas of anti-allergic, anti-infective, central nervous system, cardiovascular system, dermatology, diabetes, gastroenterology, gynecology, nephrology, oncology, ophthalmology, orthopedic, pain, respiratory, rheumatology, and urology. In addition, it provides logistical and marketing services for the sale of goods manufactured by third parties, social enterprise, and wellness center, as well as involved in the software design, development, and other services business. The company was incorporated in 1982 and is headquartered in Bangkok, Thailand. Mega Lifesciences Public Company Limited operates as a subsidiary of Unistretch Limited.

www.megawecare.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MEGA.BK

View More

Performance Overview: MEGA.BK

Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

MEGA.BK
20.65%
MSCI WORLD (^990100-USD-STRD)
4.14%

1-Year Return

MEGA.BK
33.08%
MSCI WORLD (^990100-USD-STRD)
11.38%

3-Year Return

MEGA.BK
45.39%
MSCI WORLD (^990100-USD-STRD)
45.82%

5-Year Return

MEGA.BK
12.00%
MSCI WORLD (^990100-USD-STRD)
85.13%

Compare To: MEGA.BK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MEGA.BK

View More

Valuation Measures

Annual
As of 5/20/2025
  • Market Cap

    23.32B

  • Enterprise Value

    19.89B

  • Trailing P/E

    11.73

  • Forward P/E

    10.66

  • PEG Ratio (5yr expected)

    106.57

  • Price/Sales (ttm)

    1.57

  • Price/Book (mrq)

    2.26

  • Enterprise Value/Revenue

    1.34

  • Enterprise Value/EBITDA

    7.47

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.35%

  • Return on Assets (ttm)

    14.53%

  • Return on Equity (ttm)

    19.59%

  • Revenue (ttm)

    14.86B

  • Net Income Avi to Common (ttm)

    1.98B

  • Diluted EPS (ttm)

    2.28

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.91B

  • Total Debt/Equity (mrq)

    4.62%

  • Levered Free Cash Flow (ttm)

    1.84B

Research Analysis: MEGA.BK

View More

Company Insights: MEGA.BK

Research Reports: MEGA.BK

View More

People Also Watch